Filter
889
Filtered Results: 889
Text search:
The
Pharmacy
and
Drugs
Distribution
Featured
Recommendations
76
New Publications
327
Language
Document type
No document type
560
Studies & Reports
129
Guidelines
124
Manuals
35
Strategic & Response Plan
19
Training Material
10
Situation Updates
6
Fact sheets
5
Online Courses
1
Countries / Regions
Kenya
60
Ethiopia
46
India
38
Sierra Leone
34
South Africa
34
Nigeria
33
Uganda
30
Liberia
27
Nepal
27
Rwanda
26
Malawi
25
Ghana
23
Tanzania
23
Zambia
20
Lesotho
17
Zimbabwe
16
Bangladesh
16
Namibia
16
Botswana
15
Global
11
Ukraine
10
Latin America and the Carribbean
9
Burkina Faso
8
Cameroon
8
Philippines
8
Indonesia
8
Myanmar / Burma
8
Western and Central Europe
7
Cambodia
6
Senegal
5
Congo, Democratic Republic of
5
Haiti
5
Benin
5
South–East Asia Region
5
Tajikistan
5
Guinea
4
South Sudan
4
Mozambique
4
Eswatini/ Swaziland
4
Russia
4
Pakistan
3
Thailand
3
Eastern Europe and Central Asia
3
Paraguay
3
Eastern Europe
3
Mali
2
Afghanistan
2
Lebanon
2
Syria
2
Central African Republic
2
Serbia
2
Sri Lanka
2
East and Southern Africa
2
Middle East and North Africa
2
Asia
2
Africa
2
Bhutan
2
Albania
2
Mongolia
2
Kyrgyzstan
2
Kazakhstan
2
Georgia
2
Vietnam
2
Côte d’Ivoire / Ivory Coast
1
Jordan
1
Germany
1
Egypt
1
Chad
1
China
1
Sudan
1
Brazil
1
North Macedonia
1
Libya
1
Angola
1
West and Central Africa
1
Western Pacific Region
1
Venezuela
1
Armenia
1
Laos
1
Canada
1
Timor Leste/ East Timor
1
Moldova
1
Uzbekistan
1
Gabon
1
Turkmenistan
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
539
Clinical Guidelines
45
Public Health
30
Women & Child Health
16
Capacity Building
14
Key Resources
13
Pharmacy & Technologies
13
Toolboxes
Pharmacy
97
AMR
74
HIV
67
TB
40
Mental Health
23
COVID-19
19
Caregiver
15
NCDs
11
Ebola
10
Conflict
9
Rapid Response
8
NTDs
8
Global Health Education
5
Disability
4
Refugee
4
Planetary Health
4
Natural Hazards
3
Specific Hazards
3
Zika
2
Health Financing Toolbox
2
In line with its decentralization principle, the Ethiopian Health Policy has achieved great progress in improving access to comprehensive HIV/AIDS services to the majority of ...
In the face of rapid increases in the number of hospitalizations due to COVID-19 in Latin America and t... Caribbean, coupled with shortages of human and material resources, including medical equipment and gases, there is a need to redesign models of care in the Region to optimize available resources and ensure that more patients receive the quantity and quality of oxygen they need. Oxygen is included in the World Health Organization’s list of essential medicines and is used to care for patients at all levels of integrated health services networks. The efficacy of oxygen use in the treatment of patients with respiratory conditions caused by COVID-19 has been demonstrated, but there is great opportunity to improve the effectiveness of its use if it is used in a rational, sustainable, and safe way. Bearing in mind that the efficacy of a health technology is measured by its benefit under actual conditions of use, practical actions can be taken to improve the use of medical oxygen and avoid oxygen shortages. A drug is considered to be used rationally when patients receive it according to their clinical needs, in doses appropriate to their individual needs, for an appropriate period, and at a low cost to them and their community. By providing instruction on the rational use of oxygen and promoting it, negative repercussions can be avoided, such as loss of efficacy as a result of activities related to oxygen storage, distribution, and administration. Rational use of oxygen also involves controlling waste due to leaks in storage and distribution systems, use of gas at incorrect pressures, use of incorrectly adjusted flowmeters, and disconnections, among other problems. Another aspect to consider is the provision of adequate technical support for all oxygen production systems, in terms of maintenance and calibration, availability of electrical energy, and specific knowledge about these systems. For these reasons, a set of guidelines has been put together for the development of an efficient management system to deal with situations of oxygen scarcity, both now and in the future.
this Service Delivery brief provides evidence-based strategies that can help support drug shops and pharmacies in providing a wider variety of family planning methods and information. Evidence shows...
Curriculum reform efforts to enhance training on rational medicine use (RMU) and AMR should pay particular attention to ensuring that the right topics are integrated ... the right teaching-learning methodologies are adopted.
The PHC STGs and EML should be used by healthcare workers providing care at clinics, community health centres, and gateway clinics at hospitals.
P...
Perspective on drugs
People Who Inject Drugs
In addition, the following individuals of our external expert advisory committee made instrumental contributions to the ...
Drug Distribution and Control: Preparation and Handling–Guidelines
Review 2008
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on ... prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that expertise, FIP joined efforts with the PFA and is now publishing its first-ever handbook to support pharmacists in the
area of vector-borne diseases. As the integration of the regional forums in FIP advances, such collaborative projects are tangible results of an increasingly regionally informed and regionally targeted work by FIP.
English version - This handbook sets out a the new paradigm for pharmacy practice. Its aim is to guide pharmacy educators in ... practice, to educate pharmacy students and to guide pharmacists in practice to update their skills. The handbook, which brings together practical tools and knowledge, has been written in response to a need to define, develop and generate global understanding of pharmaceutical care at all levels.
The USAID | DELIVER PROJECT, Task Order 4, developed this guide for quantifying health commodities; it will assist technical advisors, program managers, warehouse managers, procurement officers, and...
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric ...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe in...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater ... exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infections caused by AMR organisms. With drugs not listed on the essential drugs list (EDL), problems of increased morbidity, costs of extended hospitalisation and mortality are extremely serious. The problem of susceptibility to and spread of infections caused by multidrug-resistant (MDR) infectious agents is fuelled by factors such as limited access to clean water and sanitation to ensure personal hygiene, malnutrition, and the HIV/TB epidemic.
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduc...
In Vietnam, most of the examination and treatment facilities are facing with of spread of bacteria resistant to many antibiotics. The level ... speed of drug resistance are increasing, at alarming level. The burden of drug resistance is increasing due to the increasing cost of treatment, prolonged treatment,. That will affect patients’ health, community and social development. In the future, many
nations will be able to face the possibility of having no effective drugs to treat infectious diseases if they do not make appropriate interventions.
